Cardio Diagnostics Holdings (CDIO) Gains from Investment Securities (2022 - 2025)
Historic Gains from Investment Securities for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to $135096.0.
- Cardio Diagnostics Holdings' Gains from Investment Securities rose 475.32% to $135096.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $135096.0, marking a year-over-year increase of 475.32%. This contributed to the annual value of $3.6 million for FY2024, which is 3906.23% up from last year.
- According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Gains from Investment Securities is $135096.0, which was up 475.32% from $128860.0 recorded in Q2 2025.
- Cardio Diagnostics Holdings' 5-year Gains from Investment Securities high stood at $3.6 million for Q4 2024, and its period low was $122332.0 during Q1 2025.
- For the 4-year period, Cardio Diagnostics Holdings' Gains from Investment Securities averaged around $1.4 million, with its median value being $1.8 million (2022).
- Per our database at Business Quant, Cardio Diagnostics Holdings' Gains from Investment Securities skyrocketed by 4688.57% in 2023 and then plummeted by 9510.34% in 2024.
- Over the past 4 years, Cardio Diagnostics Holdings' Gains from Investment Securities (Quarter) stood at $1.8 million in 2022, then surged by 46.89% to $2.6 million in 2023, then skyrocketed by 39.06% to $3.6 million in 2024, then plummeted by 96.24% to $135096.0 in 2025.
- Its Gains from Investment Securities was $135096.0 in Q3 2025, compared to $128860.0 in Q2 2025 and $122332.0 in Q1 2025.